weight loss drug novo nordisk - Search News

News

Eli Lilly, Weight Loss

Investopedia on MSN · 3d

Novo Nordisk Stock Drops on Eli Lilly Oral Weight-Loss Drug Success, Downgrade

Key Takeways U.S.-listed shares of Novo Nordisk plunged 7% in intraday trading Thursday after rival Eli Lilly reported positive oral weight-loss drug news and BMO cut its rating for the Danish drug developer's stock.

Eli Lilly Shares Up 13% After Weight Loss Pill Appears As Effective As Ozempic And Mounjaro In Trials

Shares of Eli Lilly soared Thursday morning after the pharmaceutical giant announced a clinical trial of its once-daily weight loss pill, orforglipron, demonstrated effectiveness consistent with other injectable GLP-1 weight loss drugs, such as Lilly’s Mounjaro and Novo Nordisk’s Ozempic.

Insider on MSN · 3d

Weight loss in a pill? Eli Lilly just took a big step closer to making it happen.

Eli Lilly GLP-1 pill orforglipron could revolutionize the weight loss world by the end of 2025 after promising Phase 3 trial results.

2d

Novo Nordisk: A Price Too Low To Ignore

Novo Nordisk's stocks face YTD struggles due to trial results and tariffs, but strong fundamentals and outlook justify a Buy.

3don MSN

Why Eli Lilly Stock Is Soaring Today, While Novo Nordisk and Viking Therapeutics Slide

Lilly shares are up 14.2% in response to the news, while shares of its rivals in the GLP-1 weight loss market, Novo Nordisk ( ...

Futurism on MSN2d

Novo Nordisk Is Getting Absolutely Destroyed

Shares of Novo Nordisk, the Danish pharmaceutical company behind weight-loss drugs Ozempic and Wegovy, plummeted this week.

5d

Drugmaker Novo Nordisk warns consumers about counterfeit versions of Ozempic in US

Danish drugmaker Novo Nordisk said several hundred counterfeit units of its diabetes drug Ozempic were being distributed in the United States.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results